Editorials

Adjuvant treatment for colorectal cancer

It is now over five years since the publication of two randomised trials showing that fluorouracil and levamisole reduced the relapse rate by 40% and mortality by a third in patients with node positive colorectal cancer.^{1 2} The final report of these data was recently published, showing 168 deaths in control patients versus only 121 in patients who received adjuvant treatment (P<0.005).³ Despite these data, a recent survey of oncologists and surgeons in Britain showed that most oncologists offered adjuvant chemotherapy to appropriate patients while many surgeons remained sceptical (R Grey, personal communication).

The combination of fluorouracil and folinic acid has proved superior to fluorouracil alone in patients with advanced colorectal cancer.⁴ The Canadian and Eurpean consortium trial (IMPACT) compared adjuvant treatment with high dose fluorouracil and folinic acid with no treatment in nearly 1500 patients; it showed a 22% reduction in mortality, predominantly in patients . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Adjuvant treatment for colorectal cancer

Guru Aithal and Andrew Tanner
BMJ 1996 312: 1417. [Extract] [Full Text]

Concerns about chemotherapy are legitimate

Richard Gray and John Northover
BMJ 1996 312: 1417. [Extract] [Full Text]

This article has been cited by other articles:

• SHANAHAN, F., O'SULLIVAN, G.C., O'LEARY, C. (2000). Colorectal cancer: still a major killer despite progress on many fronts. QJM 93: 131-134 [Full text]  
• Aithal, G., Tanner, A. (1996). Adjuvant treatment for colorectal cancer. BMJ 312: 1417-1417 [Full text]  
• Gray, R., Northover, J. (1996). Concerns about chemotherapy are legitimate. BMJ 312: 1417a-1417 [Full text]  
• Slevin, M. L (1996). Author's reply. BMJ 312: 1417b-1418 [Full text]